• Anaphylaxis

Auvi-q Generic Name & Formulations

General Description

Epinephrine 0.1mg, 0.15mg, 0.3mg; pre-filled auto-injector (includes audible and visible cues for use).

Pharmacological Class


How Supplied

Cartons—2 (w. one Auvi-Q Trainer)


Generic Availability


Auvi-q Indications


Emergency treatment of allergic reactions (Type 1) including anaphylaxis.

Auvi-q Dosage and Administration

Adults and Children

<7.5kg: not established. Inject IM or SQ only into the anterolateral aspect of the thigh. 7.5–15kg: 0.1mg. 15–30kg: 0.15mg. ≥30kg: 0.3mg. May repeat another dose if needed.

Auvi-q Contraindications

Not Applicable

Auvi-q Boxed Warnings

Not Applicable

Auvi-q Warnings/Precautions


The presence of sulfite in this product should not deter use. Cardiovascular disease. Hypertension. Hyperthyroidism. Diabetes. Parkinson's disease. Injection-related complications: do not inject intravenously or into buttock (risk of Clostridial infections), digits, hands, or feet; hold leg firmly and limit movement in children prior to and during injection. Advise patient to seek medical help immediately. Train patient in use of device. Elderly. Pregnancy (Cat.C). Nursing mothers.

Auvi-q Pharmacokinetics

See Literature

Auvi-q Interactions


May be potentiated by MAOIs, tricyclic antidepressants, levothyroxine, antihistamines (eg, chlorpheniramine, tripelennamine, diphenhydramine). May be antagonized by β-blockers (eg, propranolol), α-blockers (eg, phentolamine), ergot alkaloids. Arrhythmias possible with cardiac glycosides, diuretics, or anti-arrhythmics.

Auvi-q Adverse Reactions

Adverse Reactions

Anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea, vomiting, headache, respiratory difficulties; arrhythmias; rare: serious infections (skin and soft tissue) at injection site.

Auvi-q Clinical Trials

See Literature

Auvi-q Note

Not Applicable

Auvi-q Patient Counseling

See Literature